TABLE 3.
N | Overall | Stage at Diagnosis | Age at Diagnosis | |||||
---|---|---|---|---|---|---|---|---|
Non-metastatic | Metastatic | P-value | < 40 years | >40 years | P value | |||
Overall | 85 | - | 37 (48.68%) | 39 (51.32%) | - | 47 (55.29%) | 38 (44.71%) | - |
Age | 85 | - | - | - | - | - | - | - |
Mean Age (SD) | - | 41.9 (8.4) | 42.6 (8.1) | 41.3 (9.4) | 0.491 | 35.8 (3.6) | 49.4 (6.2) | - |
Years on ARV | 44 | 3.2 (2.5) | 3.7 (2.8) | 2.9 (2.2) | 0.305 | 3.0 (2.5) | 3.4 (2.5) | 0.606 |
Average Age started ARV | 48 | 39.7 (9.4) | 41.0 (8.0) | 38.4 (11.2) | 0.388 | 32.7 (4.2) | 46.2 (8.1) | < 0.001* |
Length of HIV infection | 84 | 2.5 (2.5) | 3.39 ± 2.75 | 2.05 ± 2.15 | 0.021* | 2.4 ± 2.06 | 2.7 ± 2.93 | 0.676 |
Baseline CD4 (cells/mL3) | 82 | - | - | - | 0.210 | - | - | 0.716 |
Mean CD4 (SD) | - | 236.1 (178.3) | 258.3 (217.5) | 219.7 (148.0) | 0.368 | 211.8 (138.9) | 267.1 (216.8) | 0.165 |
0 to < 200 (%) | - | 39 (47.56%) | 18 (50.00%) | 17 (43.59%) | - | 23 (50.00%) | 16 (44.44%) | - |
200 to <500 (%) | - | 38 (46.34%) | 14 (38.89%) | 21 (53.85%) | - | 21 (45.65%) | 17 (47.22%) | - |
>=500 (%) | - | 5 (6.10%) | 4 (11.11%) | 1 (2.56%) | - | 2 (4.35%) | 3 (8.33%) | - |
Marital Status | 84 | - | - | - | 0.721 | - | - | 0.068 |
Single (%) | - | 21 (25.00%) | 11 (29.73%) | 8 (21.05%) | - | 7 (14.89%) | 14 (37.84%) | - |
Married (%) | - | 42 (50.00%) | 16 (43.24%) | 21 (55.26%) | - | 27 (57.45%) | 15 (40.54%) | - |
Divorced (%) | - | 5 (5.95%) | 3 (8.11%) | 2 (5.26%) | - | 2 (4.26%) | 3 (8.11%) | - |
Widowed (%) | - | 16 (19.05%) | 7 (18.92%) | 7 (18.92%) | - | 11 (23.40%) | 5 (13.51%) | - |
Occupation | 65 | - | - | - | 0.388 | - | - | 0.637 |
Farmer (%) | - | 10 (15.38%) | 5 (16.13%) | 4 (13.79%) | - | 5 (14.71%) | 5 (16.13%) | - |
Housewife (%) | - | 4 (6.15%) | 0 (0.00%) | 3 (10.34%) | - | 3 (8.82%) | 1 (3.23%) | - |
Business (%) | - | 7 (10.77%) | 4 (12.90%) | 2 (6.90%) | - | 2 (5.88%) | 5 (16.13%) | - |
Unemployed (%) | - | 27 (41.54%) | 14 (45.16%) | 11 (37.93%) | - | 15 (44.12%) | 12 (38.71%) | - |
Other (%) | - | 17 (26.15%) | 8 (25.81%) | 9 (31.03%) | - | 9 (26.47%) | 8 (25.81%) | - |
Tribe | 67 | - | - | - | 0.671 | - | - | 0.766 |
Bemba (%) | - | 14 (20.90%) | 4 (12.50%) | 6 (20.00%) | - | 6 (18.75%) | 8 (22.86%) | - |
Chewa (%) | - | 13 (19.40%) | 6 (18.75%) | 6 (20.00%) | - | 6 (18.75%) | 7 (20.00%) | - |
Lozi (%) | - | 5 (7.46%) | 2 (6.25%) | 3 (10.00%) | - | 3 (9.38%) | 2 (5.71%) | - |
Ngoni/Ila (%) | - | 5 (7.46%) | 3 (10.00%) | 2 (6.25%) | - | 1 (3.13%) | 4 (11.43%) | - |
Nsenga (%) | - | 7 (10.45%) | 6 (18.75%) | 1 (3.33%) | - | 5 (5.63%) | 2 (5.71%) | - |
Tonga/Toka (%) | - | 5 (7.46%) | 2 (6.25%) | 3 (10.00%) | - | 3 (9.38%) | 2 (5.71%) | - |
Tumbuka (%) | - | 3 (4.48%) | 1 (3.13%) | 2 (6.67%) | - | 1 (3.13%) | 2 (5.71%) | - |
Other (%) | - | 15 (22.39%) | 8 (25.00%) | 7 (23.33%) | - | 7 (21.88%) | 8 (22.86%) | - |
statistically significant at ≤0.05
Note: percentages in the HIV-positive and HIV-negative columns are column percentages.